Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Predictive Modeling to Support Student Success on Step 2 Clinical Knowledge: A Multi-Cohort Model.
Journal: Medical science educator
Published: September 04, 2025
A case report of primary amebic meningoencephalitis in North Florida.
Journal: IDCases
Published: June 23, 2021
Safety and effectiveness of albuterol solutions with and without benzalkonium chloride when administered by continuous nebulization.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: October 05, 2018
Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease.
Journal: Human gene therapy. Clinical development
Published: November 22, 2017
Inspiratory muscle conditioning exercise and diaphragm gene therapy in Pompe disease: Clinical evidence of respiratory plasticity.
Journal: Experimental neurology
Published: March 05, 2016
Phase I/II trial of diaphragm delivery of recombinant adeno-associated virus acid alpha-glucosidase (rAAaV1-CMV-GAA) gene vector in patients with Pompe disease.
Journal: Human gene therapy. Clinical development
Published: September 20, 2014
Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes.
Journal: Human gene therapy
Published: April 11, 2013
B-Cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe disease.
Journal: The Journal of pediatrics
Published: July 21, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026